Glow Peptides · Research Journal

GLOW 70 mg vs KLOW 80 mg: What Is in Each and How They Differ

GLOW 70 mg vs KLOW 80 mg: What Is in Each and How They Differ

Glow Peptides Research Team · 2026-09-07

For research use only. Not for human or veterinary use, diagnostic use, or in any therapeutic application.

What separates the two blends

GLOW is a three-peptide blend from Glow Peptides totalling 70 mg of peptide per vial. KLOW 80 mg is the same three peptides with KPV added, totalling 80 mg per vial. KPV is the only compositional difference between them. Both are supplied as a 3 mL vial and both are specified at ≥99.2% per component by HPLC.

What is in GLOW 70 mg

GLOW, as Glow Peptides supplies it, is a blend of three peptides held in a single lyophilized vial: BPC-157, TB-500 and GHK-Cu. The product listing states one strength figure for the vial as a whole, 70 mg, and one purity specification, ≥99.2% per component by HPLC. Those two numbers, together with the constituent list and the form, are what the Glow Peptides GLOW blend product page publishes.

Of the three constituents, GHK-Cu is the one with a formal chemical record that a researcher can check independently. PubChem, maintained by the National Library of Medicine, records the copper-bound tripeptide as prezatide copper, CID 71587328, with the molecular formula C14H23CuN6O4+, a molecular weight of 402.92 g/mol and CAS number 89030-95-5 (PubChem, Copper tripeptide-1). PubChem lists copper tripeptide-1, GHK copper and CG-copper peptide among the recorded synonyms for that same compound, gives the parent compound as glycyl-L-histidyl-L-lysine, CID 73587, and records the component compounds as glycyl-L-histidyl-L-lysine and copper. That record matters here for one reason only: it fixes the identity of a named constituent so that two listings using different names for it can be recognised as the same material. Glow Peptides also lists that constituent on its own, on the standalone GHK-Cu listing.

The table below sets out what is actually published for GLOW. It is built on the fields Glow Peptides states rather than on any division of the total, because the total is the figure the product is specified, released and sold on.

Published field — GLOW as listed by Glow Peptides
Total peptide content — 70 mg per vial
Constituents — BPC-157, TB-500, GHK-Cu
Form — Lyophilized, 3 mL vial
Appearance — Blue lyophilized powder
Purity basis — ≥99.2% per component (HPLC)
Analytical method — HPLC with UV detection coupled with mass spectrometry
Lot on record — 260130-HPC-GLO70-001
Testing laboratory — Freedom Diagnostics, United States
Certificate — Published per lot, linked from the product and from the vial's QR code

The lot row is the one to read carefully, and mostly for what it does not do. A lot number is an identifier and nothing more. It ties one vial to one certificate. It does not decode into a date, a facility, a strength or anything else that could be read off the label in place of opening the record it points to. What it does is resolve to a specific document: the certificate of analysis for GLOW lot 260130-HPC-GLO70-001 is the live example, and it reports a strength of 70 mg, a purity of ≥99.2% per component by HPLC, and a date received of 1/29/2026.

The 70 mg is the strength Glow Peptides specifies and the figure the certificate confirms for that lot. It is a total across the three constituents. Glow Peptides publishes no division of that total between BPC-157, TB-500 and GHK-Cu, and a milligram figure quoted for one of those constituents on a third-party listing is not this supplier's specification.

What is in KLOW 80 mg

KLOW, as Glow Peptides supplies it, is a blend of four peptides in a single lyophilized vial: BPC-157, TB-500 and GHK-Cu, which are the three constituents of GLOW, plus KPV. The product listing states 80 mg as the total strength and ≥99.2% per component by HPLC as the purity specification, exactly the same purity basis GLOW carries. The Glow Peptides KLOW blend product page is the source for both figures.

KPV is the constituent that distinguishes the two products, and Glow Peptides catalogues it separately as well, on the KPV product page. A researcher who wants to look at that component on its own, rather than as part of a blend, has a single-compound listing available with its own documentation trail. That is worth knowing when comparing the two blends, because it means the difference between them corresponds to a product Glow Peptides also sells in isolation.

Published field — KLOW as listed by Glow Peptides
Total peptide content — 80 mg per vial
Constituents — BPC-157, TB-500, GHK-Cu, KPV
Form — Lyophilized, 3 mL vial
Appearance — Blue lyophilized powder
Purity basis — ≥99.2% per component (HPLC)
Analytical method — HPLC with UV detection coupled with mass spectrometry
Lot on record — 260320-HP-KL80-01
Testing laboratory — Freedom Diagnostics, United States
Certificate — Published per lot, linked from the product and from the vial's QR code

The same qualification applies as it does to GLOW, and it is worth repeating rather than assuming a reader carried it down the page. The 80 mg figure is a total across four constituents rather than three. Glow Peptides does not publish a division of that total between them, and the document that governs any particular vial is the certificate of analysis for KLOW lot 260320-HP-KL80-01. That certificate records a strength of 80 mg, a purity of ≥99.2% per component by HPLC, and a date received of 3/19/2026.

Third-party listings and forum threads circulate specific per-component milligram figures for both blends. Those figures are not Glow Peptides' published specification. They come from other sellers and from community write-ups of similarly named products across the research peptide market, and treating them as this supplier's numbers would mean attributing another company's figures to material Glow Peptides released. What Glow Peptides publishes for each blend is the total, 70 mg for GLOW and 80 mg for KLOW, and the certificate for the lot in hand is the document that confirms that total for a specific vial.

The difference is KPV, and nothing else

Set the two listings side by side and the comparison resolves to a single line. GLOW and KLOW share three constituents. KLOW carries a fourth, KPV. There is no other compositional difference between the two Glow Peptides blends, no difference in the form they are supplied in, and no difference in the purity basis on which each is specified.

Attribute — GLOW — KLOW
Total peptide content — 70 mg — 80 mg
BPC-157 — Present — Present
TB-500 — Present — Present
GHK-Cu — Present — Present
KPV — Not present — Present
Form — Lyophilized, 3 mL vial — Lyophilized, 3 mL vial
Purity basis — ≥99.2% per component (HPLC) — ≥99.2% per component (HPLC)
Lot on record — 260130-HPC-GLO70-001 — 260320-HP-KL80-01
Certificate — Published per lot — Published per lot

The naming follows the composition rather than the other way round. KLOW is the GLOW composition with KPV added, which is why the two names differ by a single letter and why the two products sit adjacent in the Glow Peptides catalogue. A researcher reading either name on a label is reading a description of what constituents are in the vial, and nothing further should be inferred from the name itself.

That is a narrower statement than it might look. It says the two products differ by one constituent and by ten milligrams of total peptide content. It says nothing about how the two compare in any other respect, because composition and total strength are the only axes on which Glow Peptides publishes a comparison, and they are the only axes on which one is drawn here.

What the milligram figure on the label measures

This is the section that governs how every other number on the page should be read, so it is worth stating without hedging.

The 70 mg on GLOW and the 80 mg on KLOW are measures of total peptide content in the vial. They describe how much peptide material, summed across every constituent, the lot was released with. They are specification figures produced by analysis of the material, and they exist so that a vial can be checked against its documentation.

They are not a quantity to administer. A milligram figure on a research vial is a statement about what is in the container, not an instruction about what to do with it, and it should never be read as one.

They are also not a statement of potency. Total peptide content and potency are different properties measured in different ways, and a larger total does not encode a claim about how the material behaves. Glow Peptides publishes composition, strength, purity, analytical method, lot identity and certificate documentation. It does not publish potency figures, comparative potency figures, or any characterisation of what either blend does, and this page does not supply one by implication.

All Glow Peptides material is supplied for laboratory research use only. The United States Food and Drug Administration addresses this labelling category directly in its guidance Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only, issued as final guidance for industry and FDA staff in November 2013 (FDA guidance document). Research-use-only material is documented, released and supplied on that basis, and the figures on the label and the certificate are analytical specifications for the material as released.

Anything a search result, a forum thread or a vendor listing frames as a quantity, a schedule or an outcome sits outside what Glow Peptides documents and outside what this page will state. The milligram figure answers one question: how much peptide, in total, is in the vial.

Why the two blends carry different totals

The arithmetic behind the two totals is straightforward once the milligram figure is understood as a sum rather than as a per-component value. GLOW holds three constituents and is published at 70 mg. KLOW holds those same three plus KPV and is published at 80 mg. The ten milligram difference between the two published totals corresponds to the addition of the fourth constituent.

That is the whole of the explanation, and it is deliberately not extended further. It would be easy to take the ten milligram gap and reverse-engineer a per-component figure for KPV, and then to reason backwards to figures for the other three. That inference does not hold. A blend total is a specification for the blend as released, and how a manufacturer arrives at it is a formulation question. Subtracting one published total from another does not answer that question, and the answer is not something Glow Peptides publishes.

The practical consequence for a researcher comparing the two products is that the totals are comparable to each other as totals, and that is the level at which they are meant to be read. Ten milligrams separate the published strengths. One constituent separates the compositions. Both statements are supported by what Glow Peptides publishes, and neither requires an assumption about how either total divides.

How each blend's strength appears on its certificate

Every Glow Peptides certificate of analysis page carries the same set of fields, which makes the two blends directly comparable document to document. Those fields are the product name, the bottle lot, the strength, the date received, the form, the purity, the released status, a COA verified marker, a link to the official certificate PDF, and a QR verification code.

The laboratory is named on the certificates themselves rather than described in the abstract. Testing is carried out by Freedom Diagnostics in the United States, and each certificate is signed by Stephen Schmidt, Principal Chemist. Each certificate also carries an accession number and a search code, which means a lot can be looked up at the laboratory independently of the supplier rather than only through the page the supplier publishes. The method is stated on the certificate as well: all chemical analysis is performed by HPLC with UV detection coupled with mass spectrometry, with purity determined by HPLC-UV and identity by LC-MS.

The strength field is where the milligram figure appears on the certificate, and it is stated for the lot rather than for the product line in the abstract. GLOW lot 260130-HPC-GLO70-001 reports a strength of 70 mg. KLOW lot 260320-HP-KL80-01 reports a strength of 80 mg. The lot code itself carries no information beyond identity. It is the string that ties a physical vial to one specific released lot, and it should be used to open the record rather than read as though it encoded the record's contents.

Certificate field — GLOW lot — KLOW lot
Bottle lot — 260130-HPC-GLO70-001 — 260320-HP-KL80-01
Strength — 70 mg — 80 mg
Purity — ≥99.2% per component (HPLC) — ≥99.2% per component (HPLC)
Appearance — Blue lyophilized powder — Blue lyophilized powder
Form — Lyophilized, 3 mL vial — Lyophilized, 3 mL vial
Date received — 1/29/2026 — 3/19/2026
Testing laboratory — Freedom Diagnostics, United States — Freedom Diagnostics, United States

Both blend certificates carry a determination the summary field list does not hint at. Endotoxin testing appears on every Glow Peptides certificate checked, performed per USP <85> Bacterial Endotoxins Test and USP <161>, run in duplicate, with both replicates recorded as a pass. That is a separate question from either purity or identity, and like the rest of the certificate it is reported for the individual lot rather than as a general statement about the product line.

Every vial Glow Peptides ships carries a QR code that opens the certificate for that exact lot, showing the purity, identity and test date for the material in hand rather than for the product line generally. Glow Peptides sets out how to read each field in its guide to reading a certificate of analysis. The check a researcher should actually perform is a simple one: read the lot code printed on the vial, open the certificate that code resolves to, and confirm that the strength stated there is the strength expected for that product.

How purity is reported when one vial holds several peptides

A single-compound vial can carry a single purity figure, because there is only one substance to characterise. A blend cannot, and this is why the specification on both GLOW and KLOW reads ≥99.2% per component (HPLC) rather than ≥99.2% flat.

Per-component purity means each constituent in the vial is specified in its own right. For GLOW, that is three separate determinations, one each for BPC-157, TB-500 and GHK-Cu. For KLOW, it is four, adding KPV. Each has to meet ≥99.2% by HPLC on its own for the lot to be released on that specification. It is a stricter framing than a single combined number, because a blend average could in principle be carried by one very pure constituent while another fell short, and a per-component specification closes that gap.

The method matters as much as the number. High performance liquid chromatography separates the constituents of a mixture so that each can be quantified individually, which is what makes a per-component figure possible for a multi-peptide vial in the first place. Glow Peptides explains how purity is measured and reported in its explainer on HPLC and mass spectrometry purity testing, and the broader documentation approach is set out on the quality and testing page.

Two points follow for anyone comparing GLOW and KLOW. First, the purity specification is identical across both blends, so purity is not a point of difference between them. Second, ≥99.2% per component is the specification stated on the product pages and on both live blend certificates, and that is the figure to work from. Where a purity value is being recorded internally for a particular vial, it should be taken from the certificate for that lot rather than from a general product description, because the certificate is the document that describes the material actually received.

The documentation that travels with a vial, and the check to run on receipt

Both blends are supplied in the same physical format, a lyophilized preparation in a 3 mL vial, and the form is recorded as a field on the certificate rather than left to the product description alone. That means the form a researcher receives can be verified against the released record for that lot in the same motion as the strength and the purity.

Handling a blend has one requirement that a single-compound vial does not impose quite so sharply, and it is a documentation requirement rather than a physical one. Because the vial holds several peptides characterised individually, the certificate is the only place the full picture of that lot exists: the constituent list, the total strength, the per-component purity determinations, the identity confirmation, the appearance recorded on receipt, and the endotoxin result. Separate a vial from its lot code and that record becomes difficult to recover, because the lot code is the only thing linking the two. Keeping the labelled vial, the lot code and the QR code together is what preserves the ability to verify anything about the material later.

Specific storage conditions for a given lot belong to the documentation that ships with it, and this page does not restate them from memory or from general convention. The correct source is the certificate and the accompanying documentation for the lot in hand. What can be stated generally is that Glow Peptides material is supplied for laboratory research use only and is handled on that basis throughout, consistent with the research-use-only distribution category the FDA guidance cited above addresses.

The receiving check worth building into a routine is short. Confirm the product name on the vial matches the product ordered. Read the lot code and open the certificate it resolves to, using the QR code on the vial. Confirm the strength field reads 70 mg for a GLOW lot or 80 mg for a KLOW lot. Confirm the purity field reads ≥99.2% per component by HPLC. Confirm the released and COA verified markers are present. Confirm the linked laboratory PDF carries the same lot number and is signed by the laboratory named on it. Six checks, all documentary, all completed before the vial is put to any use.

Frequently asked questions

What is the difference between GLOW and KLOW?

KPV. GLOW from Glow Peptides is a blend of BPC-157, TB-500 and GHK-Cu, published at 70 mg total peptide content. KLOW from Glow Peptides is the same three constituents with KPV added, published at 80 mg total. That fourth constituent is the only compositional difference between the two products. Both are supplied as lyophilized material in a 3 mL vial and both are specified at ≥99.2% per component by HPLC.

What does the 80 mg in KLOW 80 refer to?

It refers to the total peptide content of the KLOW vial, summed across all four constituents. It is not the amount of any single component, and it is not a quantity to administer. Glow Peptides publishes 80 mg as the catalogue strength for KLOW, and the certificate of analysis for each KLOW lot reports the same figure in its strength field for that specific released lot.

Is KLOW 80 stronger than GLOW 70?

KLOW contains more total peptide material than GLOW, 80 mg against 70 mg, and it contains one more constituent, KPV. That is a difference in composition and in total peptide content, and it is the only sense in which the comparison can be made. Glow Peptides does not publish potency figures for either blend, and the milligram totals are not statements of potency.

Does the milligram figure describe each peptide or the whole vial?

The whole vial. The 70 mg on GLOW and the 80 mg on KLOW are totals across every constituent in the blend, not per-component figures. Glow Peptides publishes those totals in its catalogue listings, and the certificate of analysis for each lot confirms the same figure in its strength field for that specific released batch. No division of the total between the individual constituents is published, and milligram figures for individual constituents that circulate on third-party listings are not this supplier's specification.

How do I check the strength of the lot I received?

Read the lot code on the vial and open the certificate that code resolves to, using the QR code every Glow Peptides vial carries. The certificate reports the strength for that exact lot, alongside the purity, the identity, the appearance, the form, the date received, the released status and a link to the official PDF issued by Freedom Diagnostics in the United States. That PDF carries an accession number and a search code, so the lot can also be looked up at the laboratory independently of the supplier. GLOW lots read 70 mg and KLOW lots read 80 mg in the strength field.

Sources

View KLOW Blend research material · More research articles · Browse research peptides